Triple-negative breast cancer (TNBC)—defined by the absence of the oestrogen receptor/progesterone receptor and human epidermal growth factor receptor 2 (HER2) expression—represents approximately 15% of invasive BC. This evidence concerns the gene ERBB2 and breast cancer.